- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Flu Shot During Pregnancy; Liquid Biopsy for NSCLC; Physician-Generated Revenue
Researchers have confirmed that there is no link between flu shots and miscarriages; a liquid biopsy is as effective as tissue-based testing for identifying treatment for lung cancer; and physicians generate an average of $2 million a year for hospitals.
No Link Between Flu Shot, Miscarriage
Researchers who previously raised questions about the safety of getting a flu shot during pregnancy have announced data from their most recent study showing that there is no link between the vaccine and miscarriage. According to STAT News, the current study was bigger than the first and looked specifically at this link. The study will be submitted to a peer-reviewed journal for publication.
Liquid Biopsy for Lung Cancer Treatment
The liquid biopsy test Guardant360 is as effective as standard-of-care tissue genotyping tests for detecting biomarkers and thus guiding treatment for patients with metastatic non-small cell lung cancer, according to a press release from the American Association for Cancer Research. The test, which also has quicker turn-around time than the standard of care, can identify 1 prognostic and 7 predictive biomarkers in the blood.
Physicians Bring in $2 Million a Year for Hospitals
A survey from Merritt Hawkins revealed that physicians are major drivers of revenue for hospitals, generating an average of $2,378,727 per year in net revenue for their affiliated hospital. Cardiovascular surgeons landed the top spot on the list, generating an average of nearly $3.7 million a year, followed by invasive cardiologists at $3.5 million, neurosurgeons at $3.4 million, and orthopedic surgeons at $3.3 million.
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients
August 13th 2025Ambulatory cardiac monitors’ clinical and economic outcomes vary; one long-term continuous monitor brand showed greater arrhythmia diagnosis, fewer retests and cardiovascular events, and lower health care resource use and costs.
Read More
